← Browse by Condition
Medical Condition

coronary artery disease cad

Total Trials
5
Recruiting Now
5
Trial Phases
Various

ClinicalMetric tracks all active clinical trials for coronary artery disease cad sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — coronary artery disease cad Clinical Trials

How many clinical trials are currently recruiting for coronary artery disease cad?
ClinicalMetric currently tracks 5 actively recruiting clinical trials for coronary artery disease cad, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 5. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for coronary artery disease cad?
coronary artery disease cad research spans multiple clinical trial phases. Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a coronary artery disease cad clinical trial?
Eligibility criteria for coronary artery disease cad trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Top Sponsors
University Medical Center Groningen 1 trial
Institute for Cardiovascular Diseases Dedinje 1 trial
Medical University Innsbruck 1 trial
The First Affiliated Hospital of Zhengzhou University 1 trial
Catharina Ziekenhuis Eindhoven 1 trial

Recruiting Clinical Trials

NCT07269366
Recruiting
Surgical Versus Percutaneous Revascularization in Patients With Reduced Left Ventricular Function (STICH 3.0-NL)
Enrollment
358 pts
Location
Netherlands
Sponsor
University Medical Center Gron...
View Trial →
NCT06659367
Recruiting
Dedinje FFR/QFR Registry
Enrollment
2,500 pts
Location
Serbia
Sponsor
Institute for Cardiovascular D...
View Trial →
NCT07107568
Recruiting
Assessment of Coronary Artery Disease Before Transcatheter Aortic Valve Replacement: A Randomized, Multicenter, Non-Inferiority Trial
Enrollment
700 pts
Location
Austria
Sponsor
Medical University Innsbruck
View Trial →
NCT07463664
Recruiting
Clinical Outcomes of Drug-Coated Balloons in the Treatment of Patients With Coronary De Novo Chronic Total Occlusion Lesions
Enrollment
200 pts
Location
China
Sponsor
The First Affiliated Hospital ...
View Trial →
NCT07314138
Recruiting
Multivessel Minimally Invasive Coronary Bypass Grafting as HYBRID Revascularization Versus Conventional Off-pump Coronary Artery Bypass Grafting
Enrollment
250 pts
Location
Belgium, Netherlands
Sponsor
Catharina Ziekenhuis Eindhoven
View Trial →

Related Conditions

coronary artery disease (1) multivessel coronary artery disease (1) cabg (1) cabg in low ef (1) heart failure (1) pci (1) revascularization (1) fractional flow reserve (1) aortic valve stenosis and insufficiency (1) transcatheter aortic valve replacement tavr (1) chronic total occlusions of coronary arteries (1) chronic total occlusion cto (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology